CathPrint works closely with customers to design and produce catheters and has established small-scale production for customers at its premises. CathPrint is based in Stockholm, Sweden, and serves a variety of customers.
CathPrint AB, owner of the CathPrint Technology® - an innovative platform for applying flexible
printed circuit boards on advanced catheters enabling a very cost-efficient incorporation of electronic
components within catheters, today announce the appointment of Tim Lenihan as regular board member and Chris Minar
as deputy board member.
At the CathPrint Extra General Meeting of June 10 2021, Tim Lenihan was appointed board member of CathPrint AB and Chris Minar appointed deputy member of the board.
CathPrint works with partnerships for the Next Generation catheter technology platform to offer attractive and cost-efficient solutions for companies operating within the global business of advanced catheters.
Tim Lenihan is the Co-Founder of MD Start, where he has been the acting CEO of LimFlow, the 4th company created and incubated by MD Start I which focuses on critical limb ischemia and aims at restoring blood flow to the limb. More recently he was the CEO and then CTO of preCARDIA, the second company created, funded and incubated by MD Start II. Prior to founding MD Start in 2010, Tim was CEO and Founder of Contract Medical International GmbH (CMI) a contract developer and manufacturer of catheter based medical devices headquartered in Dresden Germany with facilities in both Germany and the Czech Republic.
Tim Lenihan: “I very much like the CathPrint Technology® and the simplicity of the CathPrint approach and am excited to help find new applications for the technology”
Chris Minar is president at Sand Creek Medtech, a medical device consulting company. He is also Vice President of Research and Development for Intershunt technologies. He is an endlessly curious innovation leader with broad experience across multiple industries, including close to 30 years in the medical device field, where he led the development and commercialization of products for strategic companies, contract development organizations, and start-ups.
Chris Minar: “I have gained significant experience developing products designed to leverage the potential for machine learning in both cardiology and neurology. I strongly believe that CathPrint has a unique opportunity to help maximize the potential of such devices by enabling them to have more sensors at a lower cost. I am excited to help the innovative CathPrint team realize its vision and improve patient lives.”
Agneta Edberg, Chairman of CathPrint: “I am very pleased to welcome Tim & Chris to the CathPrint Board and I am confident that they, with their highly relevant extensive experience and skills, will play an important role in supporting CathPrint in the upcoming phase of commercializing the CathPrint Technology®”
Posted 18 June 2021
CathPrint AB announces a seven year exclusive supply agreement with Trackwise Designs Plc for its IHT technology to be used for CathPrint’s next generation catheter technology. This secures CathPrint’s development and production of advanced catheters and further protects its technology platform.
Bengt Källbäck, CTO of CathPrint: “We have had a successful cooperation with Trackwise to develop our technology platform and now look forward to keep working with them in the commercialization phase. Their unique competence in this area is key to our continued expansion.”
Philip Johnston, CEO of Trackwise: “We’re delighted to be supporting CathPrint, in their innovative work in catheter development and manufacturing. Today’s multi-year agreement demonstrates the wide applicability of IHT to diverse end-market, the skills of our engineers in meeting the needs of multiple markets and underlines our confidence in the opportunity for Trackwise.”
Posted 30 April 2021
CathPrint AB, today announces the appointment of Jacob Ahlsson as new CEO.
Jacob Ahlsson, MSc. BA at Linköping University has more than 20 years’ experience from leadership positions in the Med Tech industry & Management Consulting in Life Science. Awarded Pharmaceutical Profile of the Year 2017 in Sweden (Läkemedelsmarknaden/Bonnier).
CathPrint works with partnerships for its next generation catheter technology platform to offer attractive and cost-efficient solutions for companies operating within the global business of advanced catheters and through adding Ahlsson’s experience to the Company this will contribute to an increased focus on business development and partnerships.
Jacob Ahlsson, “I am really excited to join the Med Tech start-up CathPrint AB now when the company is just about to start the commercialization process of its unique and proprietary technology. I am confident that it will make a significant positive difference in the global business for advanced catheters.”
Agneta Edberg, Chairman of the Board, “The Board of Directors welcome Jacob as our new CEO and important part of the management team. His leadership and Med Tech business experiences will be a perfect match for implementing the strategic goals for CathPrint”
Posted 1 March 2021
CathPrint and its CEO Elin Mignérus was named on this year’s list of inspiring companies and entrepreneurs, established by organization Företagarna and ALMI. “We are very excited to see CathPrint’s innovative technology receive attention for its huge potential, and I am of course flattered to be mentioned amongst this crowd of inspiring people” says CathPrint CEO Elin Mignérus.103 young ideas is published every year by Företagarna and ALMI and contains the most inspiring companies and entrepreneurs to be watched. Find the full list here: 103 unga idéerFöretagarna is Sweden’s largest organization for SMEs and represents over 60,000 companies.Almi Företagspartner AB is owned by the Swedish state and is the parent company of a group consisting of 16 regional subsidiaries and the Almi Invest AB subgroup.
Posted 25 September 2020
As a part of the Headstart program by EIT Health, CathPrint has received €50,000 to support the development of our smart catheters. The grant will support activities during the next 12 months.About the programThe EIT Health Headstart Programme provides funding of up to €50 000 to support early stage companies and SMEs in developing new products and services. Selected companies will work on their product launch project with support from the regional managers to access local and EIT Health networks.Find out more at EIT Health website
Posted 1 October 2019
Earlier this spring, CathPrint was awarded the “SME Instrument – Runner-up” grant from Sweden’s Innovation Agency, Vinnova. The grant is provided to companies who receive a Seal of Excellence from the European Commission in the assessment of applications for the SME Instrument.The grant of SEK500,000 is provided to support CathPrint in the development of advanced, multi-electrode catheters, and will give us the opportunity to speed up our efforts to launch the first working prototype of the Smart-Cath concept.
Posted 10 June 2019
In spring 2019, CathPrint had a successful revision of our quality management system. Together with passing the revision we also transitioned to the updated standard ISO13485:2016, and are now certified for design solutions, prototype development and development of manufacturing process for advanced catheters/probe parts.
Posted 17 April 2019
Following an election in December 2018, CathPrint has welcomed two new members of the Board of Directors;
- Agneta Edberg is now Chairman of the Board. She has extensive experience from the life science sector, both in executive positions and from board work. Previous work includes board positions in private and public companies, as well as Marketing Director at Pharmacia and Pfizer, among others.
- Malin Nilsson (PhD) is now a member of the Board. Malin is the inventor of bone supplement Cerament, and has a background in research, product management and business development. She is currently CEO of Inossia AB and on the Board of Directors for BoneTrigger AB.
CathPrint hires new CEO Elin Mignérus, starting January 1st. Elin has an M.Sc. in Biomedical engineering from KTH Royal Institute of Technology and has a minor in technopreneurship from the National University of Singapore, and has experience with medical device innovation and digital health.
CathPrint becomes a catheter producer for Spiro Medical. CathPrint catheter technology is now being used by patients through Spiro'Sleep Related Breathing Disorder application.
CathPrint collaborates with M Dialysis
CathPrint collaborates with MRA Medical in designing and producing the Spiro Apnea diagnostic catheters bringing in CathPrint's first million Swedish Kronor.
Winner of the 2006 SKAPA-pris, the Swedish championship prize in innovation, awarded by the Swedish Inventors’ Association (SvenskaUppfinnarföreningen) and ALMI (ALMIFöretagspartner AB)
CathPrint is typically interested in recently graduated electrical engineers or students searching for a Master Thesis with a basic knowledge of electrical schematics. The perfect candidate would also have a medical background and know about MEMS (Microelectromechanical Systems), pressure, temperature and oxygen sensors.
Kindly send your CV and a motivation letter to email@example.com.
For specific prototypes or long-term cooperation, feel free to contact us about your project and our experts will come back to you shortly with a technical opinion. For demonstration purposes, testing a prototype is a quick and efficient way to evaluate the suitability of our technology for your application. Please get in touch to discuss your catheter requirements.